Post-cholecystostomy outcomes were comparable between short-course and long-course antibiotics, consistent with emerging literature supporting short-course antibiotics for intra-abdominal infection with source control” Walker et al (2018).
BACKGROUND: Current guidelines do not specifically address optimal antibiotic duration following cholecystostomy. This study compares outcomes for short-course (<7 days) and long-course (≥7 days) antibiotics post-cholecystostomy. METHODS: This was a retrospective review of cholecystostomy patients (≥18 years) admitted (1/1/2007-12/31/2017) to one healthcare system. RESULTS: Overall, 214 patients were studied. Demographics were similar, except short-course patients had higher Charlson Comorbidity Index (p < 0.0001). There were no intergroup differences in tachycardia (22.5% vs 23.3%) or leukocytosis (67.1% vs 64.4%) at drain placement nor time to normalization for pulse, temperature or leukocytosis. There were no differences regarding Clostridium Difficile infection (5.0% vs 1.6%) or cholecystitis recurrence (8.8% vs 10.9%). No differences were observed regarding gallbladder-related unplanned readmissions (30-day:18.8% vs 17.2%; 90-day: 20.0% vs 25.8%). There were no 30- or 90-day mortality differences (overall mortality: 18.3%). CONCLUSION: Post-cholecystostomy outcomes were comparable between short-course and long-course antibiotics, consistent with emerging literature supporting short-course antibiotics for intra-abdominal infection with source control.
You may also be interested in…
Walker, C., Young, K., Moosavi, A., Molacek, N., Dove, J., Hunsinger, M., Blansfield, J., Widom, K., Torres, D., Gregory, J. and Wild, J. (2018) Cancel that PICC line order; cholecystostomy tube and short course of antibiotics. American Journal of Surgery. October 29th. .